Prediction: Buying Enterprise Products Partners Today Could Set You Up for Life
The company is one of the most consistent in the midstream space.
Using a DRIP is a great way to set you up for a meaningful income stream when it comes time for retirement.
10 stocks we like better than Enterprise Products Partners ›
Buying stock in midstream energy giant Enterprise Products Partners (NYSE: EPD) could set you up for life. Now, that doesn't mean the stock is going to skyrocket and make you a millionaire overnight on a modest investment. Instead, what buying Enterprise's stock will give you is a lifetime of solid and growing passive income.
Enterprise currently sports an attractive forward yield of 6.9%. But the beauty of Enterprise is that the pipeline management company has also increased its distribution in each of the past 26 years, both in good and bad energy markets. Last quarter, the company increased its quarterly payout by 3.9% year over year to $0.535 per unit.
If Enterprise were to increase its distribution by a similar amount moving forward, its distribution would approximately double over the next 20 years. With a payout of nearly $4.50 per share by that time, your "personal yield" on an investment in Enterprise at that time would be a little over 13.6% based on the stock's current levels today. While "personal yield" is not a standard financial term, it is simply the yield you are getting based on your personal cost basis (the stock's current dividend/your cost basis).
Now, if Enterprise were to keep raising its distribution at this same pace for the next 30 years, its payout would get to $6.75 per share each year. That would be about a 20% personal yield if you bought the stock today. So if you're between 30 and 40 years old, that would set you up with a nice, very high-yield income stream just as you were entering retirement.
Another attractive thing with Enterprise is that it's structured as a master limited partnership (MLP), which means it pays distributions instead of traditional dividends. The key difference is tax treatment. A large portion of these distributions is typically classified as return of capital, which isn't taxed immediately. Instead, it lowers your cost basis in the stock.
Once your cost basis hits zero, any additional distributions are taxed as capital gains, and when you sell, you'll pay taxes on the deferred portion of distributions at the ordinary income tax rate, which should be lower when you're retired. The rest of the gains are taxed as capital gains.
Because of its preferential tax treatment, many investors also don't take the distribution when they are younger. Instead, they use what is called a DRIP, or dividend reinvestment plan. These are plans offered by companies where they will automatically reinvest your distributions back into the stock at no commission in lieu of a cash payment. Using a DRIP to reinvest your distributions over a couple of decades can turn your initial investment into a significant income stream when it's time to retire and start collecting the payouts.
What helps separate Enterprise from other high-yield stocks is its consistency. The company has always taken a conservative approach, which has allowed it to weather any economic or energy market storms. Enterprise owns one of the largest integrated midstream companies in the U.S., and it is particularly strong in the natural gas liquids (NGLs) space.
NGLs, which include ethane, propane, butane, isobutane, and natural gasoline, are high-value by-products of natural gas and crude oil production. Ethane is one of the main feedstocks in the petrochemical industry to produce plastics and chemicals, while butane can also be used as a petrochemical feedstock, as well as for heating and cooking. The other three tend to be blended into fuels. There is also a large U.S. export market for both propane and butane, and Enterprise is heavily involved throughout the entire NGL value chain.
Meanwhile, the company takes several measures to ensure the predictability of its cash flows. Approximately 85% of its business historically comes from fee-based services that aren't impacted by energy prices or commodity spreads. At the same time, it likes to include take-or-pay provisions in its initial contracts, which assures it gets paid no matter whether customers use its services. It also attaches yearly inflation escalators to its contracts, as well.
Additionally, Enterprise has always maintained a conservative balance sheet and robust distribution coverage ratio. Building pipelines and other midstream assets is a capital-intensive business, so midstream companies carry debt. Given the strong cash flows and predictable nature of midstream assets, many companies target leverage -- net debt/adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) -- in the 4x to 4.5x times range.
However, Enterprise has always taken a more cautious approach, ending Q1 with leverage of only 3.1 times and an investment-grade credit rating on its debt. Today, the company largely self-funds its growth projects through its cash flows, although it will take on some additional debts to pursue attractive growth projects.
At the same time, the company's distribution is well covered by its distributable cash flow, which is its operating cash flow minus maintenance capital expenditures. Last quarter, its coverage ratio was 1.7 times, which gives it ample room to continue to increase its distribution in the years ahead.
Overall, Enterprise is a sleep-well-at-night stock that can help set up investors for life, offering solid price appreciation potential to go along with an attractive and rising distribution.
Before you buy stock in Enterprise Products Partners, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Enterprise Products Partners wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!*
Now, it's worth noting Stock Advisor's total average return is 994% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of June 9, 2025
Geoffrey Seiler has positions in Enterprise Products Partners. The Motley Fool recommends Enterprise Products Partners. The Motley Fool has a disclosure policy.
Prediction: Buying Enterprise Products Partners Today Could Set You Up for Life was originally published by The Motley Fool
Erreur lors de la récupération des données
Connectez-vous pour accéder à votre portefeuille
Erreur lors de la récupération des données
Erreur lors de la récupération des données
Erreur lors de la récupération des données
Erreur lors de la récupération des données
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025
REDWOOD CITY, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial results for the second quarter of 2025 on Wednesday, August 6, 2025, after market close. At 4:30 p.m. ET that day (1:30 p.m. PT), members of Revolution Medicines' senior management team will host a webcast to discuss the financial results for the quarter and provide an update on corporate progress. To listen to the live webcast, or access the archived webcast, please visit: Following the live webcast, a replay will be available on the company's website for at least 14 days. About Revolution Medicines, Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; and zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor, are currently in clinical development. The company anticipates that RMC-5127, a RAS(ON) G12V-selective inhibitor, will be its next RAS(ON) inhibitor to enter clinical development. Additional development opportunities in the company's pipeline focus on RAS(ON) mutant-selective inhibitors, including RMC-0708 (Q61H) and RMC-8839 (G13C). For more information, please visit and follow us on LinkedIn. Revolution Medicines Media & Investor Contact:media@
Yahoo
10 minutes ago
- Yahoo
Board Declares Quarterly Dividend and Elects New Officer
WESTMINSTER, Colo., July 30, 2025 /PRNewswire/ -- Ball Corporation's (NYSE: BALL) board of directors (the "Board") today declared a cash dividend of 20 cents per share, payable September 16, 2025, to shareholders of record as of September 2, 2025. The Board also elected Edmund "Ted" Doering to serve as Chief Information Officer (CIO) of the corporation. Ted recently joined Ball to succeed Brian Gabbard, who is planning to retire from the company at the end of September. Ted brings more than three decades of global IT leadership experience, most recently serving as executive vice president and CIO at Berry Global. Before joining Berry, Ted was Chief Digital Officer at Emerson Electric and CIO of Emerson Automation Solutions. Ted has deep expertise in driving value creation, delivery execution and enterprise risk management. Conference Call Details Ball will announce its second quarter 2025 earnings on Tuesday, August 5, 2025 before trading begins on the New York Stock Exchange. At 9 a.m. Mountain Time on that day (11 a.m. Eastern Time), Ball will hold its regular quarterly conference call on the company's results and performance. Please use the following URL to join via webcast: To participate in the live call Q&A session, North American callers should use the following number, 877-497-9071. International callers should use the following number, +1 201-689-8727. For those unable to listen to the live call, a taped replay and transcript of the event will be available within 48 hours on Ball's website at under "Financial Results." About Ball Corporation Ball Corporation supplies innovative, sustainable aluminum packaging solutions for beverage, personal care and household products customers. Ball Corporation employs 16,000 people worldwide and reported 2024 net sales of $11.80 billion, which excludes the divested aerospace business. For more information, visit or connect with us on LinkedIn or Instagram. View original content to download multimedia: SOURCE Ball Corporation Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 minutes ago
- Yahoo
Sprouts (NASDAQ:SFM) Exceeds Q2 Expectations
Grocery store chain Sprouts Farmers Market (NASDAQ:SFM) reported Q2 CY2025 results beating Wall Street's revenue expectations , with sales up 17.3% year on year to $2.22 billion. Its GAAP profit of $1.35 per share was 9.4% above analysts' consensus estimates. Is now the time to buy Sprouts? Find out in our full research report. Sprouts (SFM) Q2 CY2025 Highlights: Revenue: $2.22 billion vs analyst estimates of $2.17 billion (17.3% year-on-year growth, 2.3% beat) EPS (GAAP): $1.35 vs analyst estimates of $1.23 (9.4% beat) Adjusted EBITDA: $217.8 million vs analyst estimates of $200.5 million (9.8% margin, 8.6% beat) EPS (GAAP) guidance for the full year is $5.26 at the midpoint, beating analyst estimates by 3.3% Operating Margin: 8.1%, up from 6.7% in the same quarter last year Free Cash Flow Margin: 2.3%, similar to the same quarter last year Same-Store Sales rose 10.2% year on year (6.7% in the same quarter last year) Market Capitalization: $15.36 billion "We are pleased with our excellent results for the second quarter," said Jack Sinclair, chief executive officer of Sprouts Farmers Market. Company Overview Playing on the secular trend of healthier living, Sprouts Farmers Market (NASDAQ:SFM) is a grocery store chain emphasizing natural and organic products. Revenue Growth Examining a company's long-term performance can provide clues about its quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. With $8.40 billion in revenue over the past 12 months, Sprouts is a mid-sized retailer, which sometimes brings disadvantages compared to larger competitors benefiting from better economies of scale. As you can see below, Sprouts grew its sales at a mediocre 7.5% compounded annual growth rate over the last six years (we compare to 2019 to normalize for COVID-19 impacts), but to its credit, it opened new stores and increased sales at existing, established locations. This quarter, Sprouts reported year-on-year revenue growth of 17.3%, and its $2.22 billion of revenue exceeded Wall Street's estimates by 2.3%. Looking ahead, sell-side analysts expect revenue to grow 10.2% over the next 12 months, an acceleration versus the last six years. This projection is eye-popping and indicates its newer products will spur better top-line performance. Software is eating the world and there is virtually no industry left that has been untouched by it. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. Click here to access a free report on our 3 favorite stocks to play this generational megatrend. Store Performance Number of Stores A retailer's store count influences how much it can sell and how quickly revenue can grow. Over the last two years, Sprouts opened new stores at a rapid clip by averaging 6.4% annual growth, among the fastest in the consumer retail sector. This gives it a chance to become a large, scaled business over time. When a retailer opens new stores, it usually means it's investing for growth because demand is greater than supply, especially in areas where consumers may not have a store within reasonable driving distance. Note that Sprouts reports its store count intermittently, so some data points are missing in the chart below. Same-Store Sales A company's store base only paints one part of the picture. When demand is high, it makes sense to open more. But when demand is low, it's prudent to close some locations and use the money in other ways. Same-store sales provides a deeper understanding of this issue because it measures organic growth at brick-and-mortar shops for at least a year. Sprouts has been one of the most successful retailers over the last two years thanks to skyrocketing demand within its existing locations. On average, the company has posted exceptional year-on-year same-store sales growth of 7.5%. This performance suggests its rollout of new stores is beneficial for shareholders. We like this backdrop because it gives Sprouts multiple ways to win: revenue growth can come from new stores, e-commerce, or increased foot traffic and higher sales per customer at existing locations. In the latest quarter, Sprouts's same-store sales rose 10.2% year on year. This growth was an acceleration from its historical levels, which is always an encouraging sign. Key Takeaways from Sprouts's Q2 Results We were impressed by how significantly Sprouts blew past analysts' revenue, EPS, and EBITDA expectations this quarter. We were also glad its full-year EPS guidance exceeded Wall Street's estimates. Zooming out, we think this was a good print with some key areas of upside. The stock traded up 2.5% to $162.01 immediately following the results. Sprouts may have had a good quarter, but does that mean you should invest right now? If you're making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here, it's free.